Auscann Group Holdings Share Price and Company Fundamentals
Last traded: Yesterday at 5:10 AM
AusCann Group Holdings Ltd researches, develops, and commercializes various cannabinoid-derived therapeutic products for humans and animals in Australia and internationally. It offers tetrahydrocannabinol and cannabidiol powder-based hard-shell capsules using Neuvis technology platform for the treatment of pain and related indications; CPAT-01, a liquid, oral veterinary medicine to treat pain and inflammation in dogs; and DermaCann, a liquid oral oil formulation containing CBD for healthy skin and immune function in dogs. The company is headquartered in West Perth, Australia.
|Primary activities||Cultivation, manufacture and supply of medical cannabis products.|
|Industry / Sector||Drug Manufacturers—Specialty & Generic / Healthcare|
|Mailing address||35 Havelock Street Level 5 West Perth WA 6005 Australia|
|Phone / Fax||61 8 6305 0705 / 61 8 6255 5031|
|Share registry||COMPUTERSHARE INVESTOR SERVICES PTY LIMITED|
Auscann Group Holdings does not pay dividends.
As of Oct 2021, following are the company executives and directors listed on Auscann Group Holdings.
|Mr. Layton Patrick Mills||Chief Exec. Officer||205.32k|
|Mr. Charles Altshuler||Chief Financial Officer||223.54k|
|Dr. Margaret Curtis||Head of R&D||93.97k|
|Ms. Susan Patricia Park B.Com., FCIS, A.C.A., M.A.I.C.D., A.C.I.S., BCom||Joint Company Sec.||45|
Profitability and management effectiveness
Return on assets
Return on equity
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Auscann Group Holdings is 39.65M and its enterprise value is 26.05M. The enterprise value to revenue ratio of AC8 is 308.36.
The AC8's stocks Beta value is 1.46 making it 46% more volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
Companies similar to Auscann Group Holdings (AC8)
Auscann Group Holdings (ASX:AC8) Frequently Asked Questions
1. What is Auscann Group Holdings's Stock Symbol?
Auscann Group Holdings trades on ASX under the ticker symbol "AC8".
2. What is Auscann Group Holdings's stock price today?
One share of AC8 stock can currently be purchased for approximately $0.105.
3. How can I contact Auscann Group Holdings?
Auscann Group Holdings's mailing address is 35 Havelock Street Level 5 West Perth WA 6005 Australia. The company can be reached via phone at 61 8 6305 0705.
4. What is Auscann Group Holdings's official website?
The official website of Auscann Group Holdings is http://auscann.com.au.
5. Which share registry manages Auscann Group Holdings's stock?
Auscann Group Holdings's stock is managed by COMPUTERSHARE INVESTOR SERVICES PTY LIMITED.